Concepedia

Publication | Closed Access

A Phase II Randomized Double-Masked Trial of Pegaptanib, an Anti–Vascular Endothelial Growth Factor Aptamer, for Diabetic Macular Edema

590

Citations

24

References

2005

Year

References

YearCitations

Page 1